Important milestone for cancer patients in Norway:
Åslaug Helland, oncologist and group leader in the department will lead a new center for clinical treatment research that receives major funding from The Research Council of Norway and the Norwegian Cancer Society:
The Research Council of Norway and the Norwegian Cancer Society have allocated 128 mill. NOK for a Centre for Clincial Treatment Research for treatment of cancer.
"This funding is an important contribution to Norwegian cancer research and will ensure that more patients will be included into clinical trials. The aim is new and better treatment alternatives for hard-to-treat cancers. We will develop next generation diagnostics and treatment for increased overall survival and quality of life for cancer patients all over Norway" says Åslaug Helland, leader of the centre.
Conferral ceremony 30. September 2021
Tine Alver and Zhi Zhao receiving their PhD ceremonial diplomas
Tine Alver and Zhi Zhao from our department, received their PhD ceremonial diplomas in the University's ceremonial hall, the Aula, on 30. September 2021.
Pagui ECK, Brant SB, Svendsen K, Frigessi A, Helland Å, Thoresen S, Jonasson C(2025) Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second-Line Treatment of Advanced Non-Small Cell Lung Cancer Pharmacoepidemiol Drug Saf, 34(7), e70181 DOI 10.1002/pds.70181, PubMed 40552731
Røssevold AH, Tekpli X, Lingjærde OC, Russnes HG, Vallon-Christersson J, Borgen E, Lømo J, Garred Ø, Dorraji E, Kristensen VN, Naume B, Kyte JA(2025) High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis Commun Med (Lond), 5(1), 234 DOI 10.1038/s43856-025-00865-z, PubMed 40523912
Fjørtoft MO, Garred Ø, Lingjærde OC, Lande KT, Ottestad L, Bergheim IR, OSBREAC, Lømo J, LaMont C, Myklebust JH, Russnes H, Huse K, Rye IH(2025) Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes BJC Rep, 3(1), 35 DOI 10.1038/s44276-025-00152-3, PubMed 40394379